The Failure Patterns of Oral Cavity Squamous Cell Carcinoma After Intensity-Modulated Radiotherapy-The University of Iowa Experience

International Journal of Radiation Oncology Biology Physics

Volumn 67, Issue 5, 2007, Pages 1332-1341

  Yao, Min ^a   Chang, Kristi ^a   Funk, Gerry F ^a   Lu, Heming ^a   Tan, Huaming ^b   Wacha, Judith ^a   Dornfeld, Kenneth J ^a   Buatti, John M ^a  

^a UNIVERSITY OF IOWA HEALTH CARE   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

IMRT; Oral cavity cancer; Patterns of failure

Indexed keywords

COMPUTERIZED TOMOGRAPHY; DISEASES; HEALTH RISKS; PATIENT MONITORING; RADIOTHERAPY;

INTENSITY-MODULATED RADIOTHERAPY (IMRT); ORAL CAVITY CANCER; PATTERNS OF FAILURE;

TUMORS;

CETUXIMAB; CISPLATIN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; DOSIMETRY; FEMALE; HIGH RISK PATIENT; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 33947547101     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.11.030     Document Type: Article

References (26)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
2. Funk G.F., Karnell L.H., Robinson R.A., et al. Presentation, treatment, and outcome of oral cavity cancer: A National Cancer Data Base report. Head Neck 24 (2002) 165-180
3. Yao M., Dornfeld K.J., Buatti J.M., et al. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma-the University of Iowa experience. Int J Radiat Oncol Biol Phys 63 (2005) 410-421
4. Chao K.S., Ozyigit G., Tran B.N., et al. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 55 (2003) 312-321
5. Lee N., Xia P., Fischbein N.J., et al. Intensity-modulated radiation therapy for head-and-neck cancer: The UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys 57 (2003) 49-60
6. Eisbruch A., Marsh L.H., Dawson L.A., et al. Recurrences near base of skull after IMRT for head-and-neck cancer: Implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys 59 (2004) 28-42
7. Eisbruch A., Kim H.M., Terrell J.E., et al. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 50 (2001) 695-704
8. Chao K.S., Deasy J.O., Markman J., et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results. Int J Radiat Oncol Biol Phys 49 (2001) 907-916
9. Karnell L.H., Yao M., and Funk G.F. Quality-of-life outcomes of oropharyngeal cancer patients after intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 66 (2006) S535-S536
10. Lin A., Kim H.M., Terrell J.E., et al. Quality of life after parotid-sparing IMRT for head-and-neck cancer: A prospective longitudinal study. Int J Radiat Oncol Biol Phys 57 (2003) 61-70
11. Parliament M.B., Scrimger R.A., Anderson S.G., et al. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity-modulated radiotherapy (IMRT) for head-and-neck cancer. Int J Radiat Oncol Biol Phys 58 (2004) 663-673
12. Yao M., Graham M.M., Smith R.B., et al. Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment: a preliminary report. Int J Radiat Oncol Biol Phys 60 (2004) 1410-1418
13. Dawson L.A., Anzai Y., Marsh L., et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 46 (2000) 1117-1126
14. Chow T.L., Chow T.K., Chan T.T., et al. Contralateral neck recurrence of squamous cell carcinoma of oral cavity and oropharynx. J Oral Maxillofac Surg 62 (2004) 1225-1228
15. Kurita H., Koike T., Narikawa J.N., et al. Clinical predictors for contralateral neck lymph node metastasis from unilateral squamous cell carcinoma in the oral cavity. Oral Oncol 40 (2004) 898-903
16. Werner J.A., Dunne A.A., and Myers J.N. Functional anatomy of the lymphatic drainage system of the upper aerodigestive tract and its role in metastasis of squamous cell carcinoma. Head Neck 25 (2003) 322-332
17. Fakih A.R., Rao R.S., Borges A.M., et al. Elective versus therapeutic neck dissection in early carcinoma of the oral tongue. Am J Surg 158 (1989) 309-313
18. Peters L.J., Goepfert H., Ang K.K., et al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: First report of a prospective randomized trial. Int J Radiat Oncol Biol Phys 26 (1993) 3-11
19. Woolgar J.A. Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol 42 (2006) 229-239
20. Feng M., Jabbari S., Lin A., et al. Predictive factors of local-regional recurrences following parotid sparing intensity modulated or 3D conformal radiotherapy for head and neck cancer. Radiother Oncol 77 (2005) 32-38
21. Ang K.K., Trotti A., Brown B.W., et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 51 (2001) 571-578
22. Cooper J.S., Pajak T.F., Forastiere A.A., et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350 (2004) 1937-1944
23. Bernier J., Domenge C., Ozsahin M., et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350 (2004) 1945-1952
24. Bernier J., Cooper J.S., Pajak T.F., et al. Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 27 (2005) 843-850
25. Bonner J.A., Harari P.M., Giralt J., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354 (2006) 567-578
26. Radiation Therapy Oncology Group. RTOG 0234: A phase II randomized trial of surgery followed by chemoradiotherapy plus C225 (cetuximab) for advanced squamous cell carcinoma of the head and neck. Available at: http://www.rtog.org/members/protocols/0234/0234.pdf . Accessed October 2, 2006.